DNE Capital
Overview
DNE Capital is a private equity investment platform of DNE Group, committed to investing in innovative companies within the “New Economy, New Infrastructure” ecosystem, with a focus on sectors including healthcare, life sciences, AI, and semiconductors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shenzhen Qianhai Yueshi Information Technology Co., Ltd. | Apr 2025 | Series B | Co-investor |
| XImaging | Dec 2023 | Series B | Co-investor |
| KouTech Medical Technology | Sep 2022 | Series A | Co-investor |
| Abogen Biosciences | Nov 2021 | Series C Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DNE Capital based?
DNE Capital is headquartered in Shanghai, China.
When was DNE Capital founded?
DNE Capital was founded in 2021.
How many portfolio companies does DNE Capital have?
DNE Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in DNE Capital's portfolio?
Recent investments visible on Caplight include Shenzhen Qianhai Yueshi Information Technology Co., Ltd., XImaging, KouTech Medical Technology, Abogen Biosciences.
What was DNE Capital's most recent investment?
DNE Capital's most recent investment on Caplight was in Shenzhen Qianhai Yueshi Information Technology Co., Ltd. in 2025.
What sectors does DNE Capital focus on?
DNE Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does DNE Capital focus on?
DNE Capital typically invests at the Mid stage.